Senores Pharmaceuticals Ltd. is a research-driven pharmaceutical company specializing in high-quality complex generics and APIs. The company delivers innovative healthcare solutions across multiple markets due to a strong international presence.
Nuvama Wealth Management Ltd has successfully closed a transaction of INR 5,820 mn (EUR 66 mn) as the BRLM to Senores Pharmaceuticals on IPO issue.
Nuvama positioned Senores Pharma as a global research-driven pharmaceutical leader and engaged marquee global and domestic investors across FIIs, DIIs, mutual funds and family offices. Nuvama played a key role in the IPO by converting key marquee LO investors driving the deal momentum & helping set pricing benchmark.
Advised in the sale of
Senores Pharmaceuticals Limited
to